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Abstract:	  Adult	  neurogenesis,	  the	  process	  of	  generating	  new	  neurons	  from	  neural	  precursors,	  is	  a	  highly	  complex	  process	  that	  is	  limited	  to	  two	  specific	  areas	  of	  the	  brain,	  the	  dentate	  gyrus	  of	  the	  hippocampus	  and	  the	  subventricular	  zone	  (SVZ).	  	  Despite	  continued	  research	  investigating	  neurogenesis	  in	  these	  two	  regions,	  we	  still	  lack	  a	  fundamental	  understanding	  of	  the	  molecular	  mechanisms	  of	  neural	  cell	  division,	  migration,	  differentiation,	  and	  integration	  in	  the	  postnatal	  brain.	  	  In	  particular,	  the	  rostral	  migratory	  stream	  (RMS),	  which	  is	  a	  cellular	  migratory	  route	  for	  newly	  generated	  neuronal	  precursors	  that	  travel	  from	  the	  SVZ	  to	  the	  olfactory	  bulb,	  will	  provide	  a	  useful	  model	  to	  address	  these	  critical	  questions	  concerning	  postnatal	  neurogenesis	  and	  cell	  migration.	  	  Specifically,	  research	  involving	  the	  class	  of	  membrane-­‐bound	  proteins	  known	  as	  Ephs	  and	  ephrins,	  which	  have	  many	  regulatory	  roles	  in	  development	  that	  persist	  in	  postnatal	  neurogenic	  regions,	  has	  helped	  to	  elucidate	  the	  complex	  regulatory	  network	  that	  governs	  neural	  stem	  cell	  migration	  in	  the	  developing	  RMS.	  	  Currently,	  it	  has	  been	  suggested	  that	  Ephs	  and	  ephrins	  are	  key	  regulators	  of	  RMS	  development,	  as	  they	  participate	  in	  contact	  mediated	  signaling	  involved	  in	  regulating	  the	  migration	  of	  neural	  cell	  precursors	  from	  the	  SVZ	  to	  the	  olfactory	  bulb.	  	  Out	  of	  this	  large	  class	  of	  receptor	  tyrosine	  kinases	  (Ephs)	  and	  associated	  ligands	  (ephrins),	  the	  receptor	  EphA4	  appears	  to	  maintain	  this	  restriction	  and	  play	  a	  crucial	  role	  in	  regulating	  proper	  RMS	  development	  in	  mammals.	  	  Research	  performed	  has	  helped	  determine	  the	  expression	  profile	  of	  EphA4	  in	  this	  developing	  brain	  region,	  its	  crucial	  role	  in	  organizing	  astrocytes	  around	  tangentially	  migrating	  stem	  cells	  in	  the	  RMS,	  and	  its	  role	  in	  cellular	  proliferation.	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Introduction:	  As	  the	  general	  understanding	  and	  appreciation	  for	  the	  field	  of	  neuroscience	  continues	  to	  grow,	  scientists	  are	  beginning	  to	  acknowledge	  the	  significant	  impact	  stem	  cell	  biology	  will	  have	  on	  current	  research.	  	  As	  a	  result,	  investigators	  across	  the	  globe	  have	  begun	  to	  investigate	  such	  topics	  as	  stem	  cell	  therapy,	  cloning,	  and	  the	  use	  of	  stem	  cells	  for	  drug	  screening	  and	  disease	  modeling	  in	  the	  hope	  that	  such	  research	  will	  provide	  the	  appropriate	  foundation	  for	  applications	  in	  humans.	  	  Similarly,	  groundbreaking	  research	  concerning	  the	  potential	  usage	  of	  stem	  cell	  therapy	  in	  the	  treatment	  of	  neurodegenerative	  diseases	  has	  also	  gained	  popularity	  as	  researchers	  have	  begun	  to	  explore	  the	  concept	  of	  neurogenesis	  in	  animal	  models.	  	  To	  be	  more	  specific,	  neurogenesis,	  or	  the	  birth	  of	  new	  neurons,	  is	  the	  process	  by	  which	  neurons	  are	  generated	  from	  neural	  stem/progenitor	  cells	  in	  the	  central	  nervous	  system.	  	  Interestingly	  though,	  the	  actual	  concept	  of	  neurogenesis	  and	  neural	  stem	  cells	  was	  first	  introduced	  and	  rejected	  by	  researchers	  at	  the	  beginning	  of	  the	  twentieth	  century.	  	  Dr.	  Santiago	  Rámon	  y	  Cajal,	  commonly	  referred	  to	  as	  the	  father	  of	  neuroscience,	  actually	  claimed,	  “In	  the	  adult	  centers	  the	  nerve	  paths	  are	  something	  fixed,	  ended	  and	  immutable.	  	  Everything	  may	  die,	  nothing	  may	  be	  regenerated”	  [1].	  	  Interestingly,	  research	  by	  Joseph	  Altman	  in	  the	  1960s	  utilizing	  tritiated	  thymidine	  as	  a	  mitotic	  label	  found	  that	  constitutive	  neurogenesis	  does	  occur	  in	  the	  hippocampus	  and	  olfactory	  bulb	  of	  the	  adult	  mammalian	  brain	  [1].	  	  This	  breakthrough	  in	  neuroscience	  has	  led	  to	  the	  characterization	  and	  present	  understanding	  of	  adult	  neurogenesis	  and	  neural	  stem	  cells.	  	  As	  a	  result,	  current	  research	  has	  established	  the	  three	  fundamental	  features	  of	  adult	  CNS	  “stem	  cells”:	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1. They	  are	  “self-­‐renewing”	  with	  the	  theoretical	  ability	  to	  produce	  daughter	  cells	  that	  are	  indiscernible	  from	  themselves.	  2. They	  are	  proliferative	  and	  continue	  to	  undergo	  mitosis	  3. They	  are	  multipotent	  for	  the	  varying	  neuroectodermal	  lineages,	  including	  the	  differing	  neural	  and	  glial	  subpopulations	  [1].	  Furthermore,	  subsequent	  research	  has	  revealed	  the	  probable	  role	  of	  growth	  factors	  for	  regulating	  neurogenesis,	  including	  epidermal	  growth	  factor	  (EGF)	  and	  fibroblast	  growth	  factor	  (FGF),	  which	  act	  as	  mitogens	  for	  neural	  progenitors	  and	  stem	  cells	  in	  vitro	  [2].	  	  Ultimately,	  this	  fundamental	  research	  has	  provided	  the	  basis	  for	  the	  investigation	  of	  neurogenesis	  as	  it	  continually	  reinforces	  the	  underlying	  fact	  that	  neural	  stem	  cells	  reside	  in	  the	  adult	  central	  nervous	  system.	  	   As	  additional	  research	  continues	  to	  elucidate	  the	  complexities	  of	  adult	  neurogenesis,	  the	  scientific	  community	  has	  concluded	  that	  this	  phenomenon	  occurs	  in	  two	  specific	  areas	  of	  the	  adult	  brain:	  the	  subgranular	  zone	  (SGZ)	  in	  the	  dentate	  gyrus	  of	  the	  hippocampus	  and	  the	  sub-­‐ventricular	  zone	  (SVZ)	  of	  the	  lateral	  ventricles	  [3].	  	  Research	  concerning	  the	  dentate	  gyrus	  of	  the	  hippocampus	  has	  revealed	  that	  immature	  neuronal	  cells	  generated	  in	  the	  subgranular	  zone	  (SGZ)	  migrate	  to	  the	  granular	  layer	  of	  the	  hippocampus	  where	  they	  differentiate	  into	  mature	  neuronal	  cells	  [2].	  On	  the	  other	  hand,	  research	  has	  found	  that	  in	  SVZ	  neurogenesis,	  neuroblasts	  are	  generated	  in	  the	  anterior	  part	  of	  the	  SVZ	  and	  migrate	  through	  the	  rostral	  migratory	  stream	  (RMS)	  to	  the	  olfactory	  bulb	  (OB)	  where	  they	  differentiate	  into	  OB	  interneurons	  [2].	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  Figure	  1.	  	  Overview	  of	  the	  SVZ/RMS/OB	  Neurogenic	  Niche.	  	  (a)	  The	  head	  of	  a	  mouse	  indicating	  the	  position	   of	   the	   brain	   and	   the	   rostral	  migratory	   stream	   (RMS;	   highlighted	   in	   red),	  which	   acts	   as	   the	  pathway	   along	   which	   neuroblasts	   migrate	   tangentially	   from	   the	   subventricular	   zone	   (SVZ)	   of	   the	  lateral	  ventricle	  to	  the	  olfactory	  bulb	  (OB).	  	  (b)	  Newly	  generated	  neuroblasts	  migrate	  from	  the	  lateral	  ventricle	   through	   the	  RMS	   to	   the	  OB,	  where	   the	  neuroblasts	  differentiate	   into	  mature	   interneurons.	  	  (c)	  A	   simplified	   diagram	  based	   on	   electron	  microscopy	   that	   depicts	   the	   cytoarchitecture	   of	   the	   SVZ	  along	  the	  ventricle.	  	  In	  this	  schematic,	  the	  ependymal	  cells	  (gray)	  form	  a	  monolayer	  along	  the	  ventricle	  wall	   with	   neuroblasts	   (red),	   astrocytes	   (green),	   and	   transit	   amplifying	   progenitors	   (TAPs;	   purple)	  forming	   the	   SVZ.	   	   (d)	   Sagittal	   and	   coronal	   diagrams	  of	   tangential	   neuroblast	   chain	  migration	   in	   the	  RMS.	   	  Astrocytes	  (green)	   form	  a	  complex	  network	  around	  the	  neuroblasts	   (red)	  and	  are	  believed	   to	  restrict	  the	  migrating	  neuroblasts	  to	  their	  pathway	  to	  the	  OB.	  	  (e)	  Upon	  reaching	  the	  OB,	  neuroblasts	  migrate	  radially	  and	  differentiate	  into	  granule	  or	  periglomerular	  cells.	  	  Adapted	  from	  “Neural	  stem	  cells	  
and	  the	  regulation	  of	  adult	  neurogenesis”	  Conover	  et	  al.	  2003.	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Central	  to	  the	  growing	  field	  of	  stem	  cell	  biology	  is	  the	  phenomenon	  of	  stem	  cell	  migration	  and	  its	  possible	  application	  in	  future	  stem	  cell	  therapies.	  	  Fortunately,	  the	  RMS	  in	  the	  mammalian	  forebrain	  is	  a	  highly	  relevant	  model	  system	  for	  the	  investigation	  of	  endogenous	  stem	  cell	  migration	  as	  it	  is	  the	  site	  of	  PSA-­‐NCAM-­‐dependent	  neuroblast	  chain	  migration	  from	  the	  SVZ	  to	  the	  olfactory	  bulb	  [4].	  	  Essential	  to	  the	  development	  and	  function	  of	  the	  RMS	  is	  the	  regulatory	  network	  of	  glial	  tubes	  that	  ensheath	  the	  tangentially	  migrating	  neuroblasts	  [4].	  	  It	  is	  believed	  that	  various	  developmental	  guidance	  molecules,	  such	  as	  Ephs	  and	  ephrins,	  which	  are	  typically	  associated	  with	  boundary	  formation	  and	  axonal	  pathfinding	  [5],	  continue	  to	  provide	  cues	  for	  stem	  cell	  differentiation	  and	  neuroblast	  migration	  within	  the	  RMS.	  	  As	  a	  result,	  research	  concerning	  the	  RMS	  will	  likely	  reveal	  potential	  molecular	  targets	  for	  therapeutic	  intervention	  that	  enable	  the	  manipulation	  of	  endogenous	  neural	  stem	  cells	  or	  autologous/artificially	  cultured	  pluripotent	  cells	  in	  vivo.	  Before	  outlining	  the	  numerous	  factors	  involved	  in	  the	  regulation	  of	  astrocyte-­‐neuroblast	  interactions	  and	  the	  control	  of	  astroglial	  permissivity,	  it	  is	  important	  to	  stress	  the	  differences	  in	  the	  development	  of	  the	  rostral	  migratory	  stream	  between	  non-­‐human	  mammals	  and	  humans.	  	  To	  begin,	  the	  SVZ	  of	  numerous	  adult	  non-­‐human	  mammals,	  including	  rodents,	  has	  been	  found	  to	  generate	  a	  large	  number	  of	  neurons	  that	  travel	  and	  integrate	  in	  the	  olfactory	  bulb	  (OB).	  	  On	  the	  other	  hand,	  research	  investigating	  the	  adult	  human	  SVZ	  has	  found	  this	  region	  to	  contain	  a	  hypocellular	  gap	  layer	  that	  separates	  the	  ependymal	  lining	  from	  a	  periventricular	  ribbon	  of	  astrocytes	  [6].	  	  	  In	  addition,	  it	  has	  been	  noted	  that	  a	  portion	  of	  these	  SVZ	  astrocytes	  can	  function	  as	  neural	  stem	  cells	  in	  vitro,	  but	  in	  
vivo	  functioning	  remains	  unknown	  [6].	  	  Based	  on	  research	  performed	  by	  Alvarez-­‐Buylla	  et	  al.,	  the	  infant	  human	  SVZ	  and	  RMS	  contain	  a	  large	  population	  of	  migrating	  immature	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neurons	  before	  18	  months	  of	  age.	  	  Unlike	  rodents	  though,	  this	  corridor	  of	  migrating	  neural	  precursors	  appears	  to	  subside	  significantly	  in	  older	  children	  and	  is	  practically	  nonexistent	  by	  adulthood	  [6].	  	  Despite	  the	  apparent	  decrease	  in	  neuronal	  migration	  in	  the	  rostral	  migratory	  stream	  of	  adult	  humans,	  research	  investigating	  this	  prolonged	  phenomenon	  in	  mouse	  models	  is	  highly	  relevant	  as	  it	  may	  lay	  the	  foundation	  for	  the	  molecular	  control	  of	  stem	  cell	  movement	  and	  integration	  following	  administration	  for	  therapeutic	  purposes.	  	   The	  migration	  of	  SVZ-­‐derived	  neuroblasts	  is	  a	  unique	  phenomenon	  involving	  characteristic	  morphological	  changes	  in	  cellular	  phenotype	  and	  diverse	  signaling	  mechanisms.	  	  To	  begin,	  neuroblasts	  have	  been	  found	  to	  slide	  along	  each	  other	  in	  organized	  chains,	  commonly	  visualized	  by	  polysialylated	  neural	  adhesion	  molecule	  (PSA-­‐NCAM)	  immunostaining	  [7].	  	  Within	  the	  astroglial	  “tunnel”	  of	  the	  RMS,	  neuroblasts	  have	  been	  found	  to	  undergo	  distinct	  stereotypical	  phases	  of	  migration	  [8].	  	  The	  first	  step	  of	  tangential	  neuroblast	  migration	  involves	  the	  extension	  of	  the	  leading	  process	  in	  the	  direction	  of	  migration,	  which	  is	  stabilized	  by	  forming	  contacts	  with	  other	  cells	  and/or	  the	  extracellular	  matrix	  (ECM)	  [8].	  	  Following	  extension,	  neuroblasts	  form	  a	  dilation	  in	  front	  of	  the	  nucleus	  that	  acts	  as	  a	  reservoir	  for	  organelles	  and	  the	  centrosome	  and	  is	  the	  site	  where	  endocytic	  trafficking	  weakens	  adhesion	  [8].	  	  Finally,	  the	  nucleus	  advances	  in	  the	  dilation,	  which	  is	  aided	  by	  myosin	  II-­‐mediated	  contraction	  at	  the	  cell	  rear	  [8].	  	  Overall,	  the	  repetition	  of	  this	  cycle	  over	  time	  results	  in	  the	  forward	  migration	  of	  neuroblasts	  toward	  the	  olfactory	  bulb	  [8].	  	   In	  addition	  to	  the	  morphological	  changes	  associated	  with	  neuroblast	  migration,	  an	  array	  of	  factors	  regulate	  RMS	  neuroblast	  migration	  across	  development,	  including	  adhesion	  and	  ECM	  molecules,	  axon	  guidance	  molecules,	  neurotransmitters,	  and	  many	  others.	  	  These	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varying	  factors	  have	  diverse	  actions	  in	  the	  developing	  RMS,	  which	  range	  from	  chemorepellant/chemoattractant	  to	  motogenic	  properties.	  	  In	  addition,	  these	  key	  extracellular	  signals	  are	  vital	  to	  the	  development	  of	  this	  cellular	  migratory	  pathway	  as	  they	  help	  control	  the	  different	  phases	  of	  neuroblast	  migration,	  which	  include	  detachment	  from	  the	  SVZ,	  migration	  along	  the	  rostral	  migratory	  stream,	  and	  radial	  migration	  upon	  reaching	  the	  olfactory	  bulb.	  	   One	  critical	  class	  of	  transmembrane	  adhesion	  molecules	  involved	  in	  RMS	  development	  is	  the	  family	  of	  integrins,	  which	  are	  composed	  of	  α1,	  αv,	  β3,	  β6,	  and	  β8	  integrin	  subunits	  among	  many	  others	  [9,	  10].	  	  For	  instance,	  research	  has	  found	  that	  the	  β8	  integrin	  subunit	  is	  expressed	  in	  the	  RMS	  of	  mice	  across	  their	  lifespan	  with	  genetic	  deletion	  of	  this	  integrin	  subunit	  causing	  tangential	  chain	  migration	  to	  be	  disrupted	  likely	  due	  to	  the	  development	  of	  disorganized	  neuroblast	  clusters	  and	  increased	  numbers	  of	  GFAP-­‐positive	  astrocytes	  in	  the	  brain	  [10].	  	  Unlike	  β8	  integrin	  subunit,	  the	  integrin	  subunit	  α1	  is	  expressed	  in	  neonatal	  mice	  along	  the	  entire	  RMS	  but	  is	  significantly	  downregulated	  from	  early	  postnatal	  stages	  to	  adulthood	  [9].	  	  As	  implicated	  by	  the	  increased	  number	  of	  integrins	  present	  along	  the	  RMS,	  their	  ligands,	  known	  as	  laminins,	  also	  have	  a	  unique	  distribution	  in	  the	  SVZ	  niche	  [11].	  	  For	  instance,	  several	  α,	  β,	  and	  γ	  laminin	  subunits	  are	  highly	  expressed	  in	  the	  RMS,	  including	  α1,	  α2,	  and	  α4	  [12].	  	  Interestingly,	  it	  has	  been	  found	  that	  RMS	  organization	  becomes	  disrupted	  in	  α2/α4	  double	  knockout	  animals.	  	  In	  these	  animals,	  the	  RMS	  becomes	  less	  compact	  indicating	  that	  integrin/laminin	  interactions	  play	  a	  crucial	  role	  in	  the	  proper	  formation	  of	  organized	  neuroblast	  chains	  [12].	  	  It	  is	  also	  important	  to	  stress	  that	  integrins	  can	  control	  the	  activity	  of	  N-­‐cadherin,	  an	  essential	  cell	  adhesion	  molecule,	  which	  is	  highly	  expressed	  along	  the	  rostral	  migratory	  stream	  and	  downregulated	  in	  the	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olfactory	  bulb,	  where	  neuroblasts	  transition	  to	  radial	  migration	  [13].	  	  As	  a	  whole,	  integrins	  and	  their	  associated	  ligands	  play	  a	  crucial	  role	  in	  the	  proper	  formation	  and	  maintenance	  of	  the	  RMS	  in	  the	  developing	  mammalian	  forebrain.	  	   Two	  additional	  molecules	  critical	  to	  RMS	  development,	  in	  particular	  radial	  migration	  within	  the	  OB,	  are	  Reelin	  and	  Tenascin-­‐R.	  	  To	  begin,	  Reelin	  is	  a	  secreted	  glycoprotein	  that	  is	  necessary	  for	  the	  development	  of	  laminated	  structures	  in	  the	  brain	  [14].	  	  After	  birth,	  Reelin	  plays	  a	  crucial	  role	  in	  causing	  RMS	  neuroblast	  chains	  to	  detach,	  which	  ensures	  appropriate	  radial	  migration	  within	  the	  olfactory	  bulb	  [15].	  	  As	  expected,	  Reelin	  mutant	  mice	  typically	  have	  an	  abnormal	  accumulation	  of	  neuroblasts	  at	  the	  end	  of	  the	  RMS	  due	  to	  hindered	  radial	  migration	  of	  this	  cell	  type.	  	  As	  a	  result,	  the	  olfactory	  bulbs	  of	  these	  mice	  lack	  the	  stereotypical	  layer	  organization	  and	  have	  a	  considerable	  reduction	  of	  newly	  generated	  neurons	  [15,	  16].	  	  Unlike	  Reelin,	  Tenascin-­‐R	  is	  an	  ECM	  component	  that	  contains	  epidermal	  growth	  factor	  (EGF)-­‐like	  domains,	  fibronectin	  type	  III	  homologous	  repeats,	  a	  cysteine-­‐rich	  amino	  terminal	  region,	  and	  a	  fibrinogen	  homologous	  domain	  [17].	  	  Despite	  these	  structural	  differences,	  it	  has	  been	  found	  that	  Tenascin-­‐R	  promotes	  the	  detachment	  of	  neuroblasts	  from	  the	  end	  of	  the	  RMS	  and	  their	  subsequent	  radial	  migration	  in	  the	  olfactory	  bulb.	  	  In	  addition,	  RMS	  architecture	  and	  tangential	  migration	  in	  TNR	  knockout	  mice	  appear	  normal,	  but	  neuroblasts	  tend	  to	  accumulate	  at	  the	  rostral	  portion	  of	  the	  RMS	  prior	  to	  entering	  the	  OB,	  which	  suggests	  an	  issue	  involving	  neuroblast	  chain	  dispersion	  [18].	  	  Currently,	  possible	  interactions	  between	  the	  Reelin	  and	  Tenascin-­‐R	  signaling	  pathways	  remain	  unknown	  despite	  their	  shared	  role	  in	  regulating	  neuroblast	  radial	  migration	  in	  the	  developing	  RMS/OB	  system.	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   In	  addition	  to	  adhesion	  and	  ECM	  molecules,	  numerous	  axon	  guidance	  molecules	  have	  been	  shown	  to	  play	  a	  significant	  role	  in	  shaping	  the	  development	  of	  the	  RMS.	  	  One	  common	  example	  is	  the	  family	  of	  Slit	  proteins	  and	  their	  associated	  Robo	  receptors	  [19,	  20].	  	  It	  has	  been	  found	  that	  two	  members	  of	  the	  Slit	  family,	  Slit1	  and	  Slit2,	  are	  expressed	  in	  the	  adult	  brain	  choroid	  plexus	  and	  septum.	  	  In	  addition,	  these	  diffusible	  proteins	  repel	  SVZ-­‐derived	  neuroblasts	  in	  vitro	  [19,	  20].	  	  Studies	  in	  Slit1	  knockout	  mice	  have	  shown	  that	  neuroblasts	  prematurely	  leave	  the	  RMS	  and	  migrate	  throughout	  the	  corpus	  callosum	  (CC)	  [21].	  	  Further	  research	  has	  revealed	  that	  the	  Slit	  receptors	  Robo2	  and	  Robo3	  are	  located	  on	  the	  migrating	  RMS	  neuroblasts	  and	  on	  the	  surrounding	  astrocytes	  [22].	  	  Slit1	  released	  by	  the	  migrating	  neuroblasts	  modulates	  astrocyte	  morphology	  in	  the	  RMS,	  ultimately	  “repelling”	  the	  surrounding	  astrocytes	  through	  Robo	  signaling.	  	  This	  repulsion	  plays	  a	  crucial	  role	  in	  the	  proper	  formation	  and	  maintenance	  of	  RMS	  astrocyte	  tunnels,	  which	  are	  vital	  to	  long-­‐range	  neuroblast	  migration	  [22].	  	   Another	  family	  of	  axon	  guidance	  molecules	  is	  the	  class	  of	  Neuregulins	  (NRGs)	  and	  their	  associated	  receptors	  ErbB2,	  ErbB3,	  and	  ErbB4,	  which	  are	  receptor	  tyrosine	  kinases	  [23].	  	  NRGs	  are	  multiple	  EGF-­‐like	  domain-­‐containing	  ligands	  that	  are	  recognized	  as	  classic	  regulators	  of	  synaptic	  plasticity	  that	  also	  play	  an	  important	  role	  in	  glial-­‐guided	  neuronal	  migration	  in	  the	  cortex	  and	  cerebellum	  during	  development	  [24,	  25,	  26].	  	  In	  regards	  to	  the	  developing	  RMS,	  it	  has	  been	  found	  that	  NRG1-­‐3	  all	  activate	  ErbB4,	  which	  is	  selectively	  expressed	  at	  increased	  levels	  in	  type	  A	  migratory	  neuroblasts,	  a	  subpopulation	  of	  GFAP-­‐positive	  astrocytes,	  and	  type	  C	  proliferating	  progenitors	  in	  the	  RMS	  and	  SVZ	  [27].	  	  Conditional	  deletion	  studies	  in	  which	  ErbB4	  was	  deleted	  in	  nestin-­‐expressing	  stem	  cells	  or	  in	  GFAP-­‐expressing	  stem	  cells	  and	  astrocytes	  resulted	  in	  fragmented	  neuroblast	  chains	  and	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jagged	  boundaries	  of	  the	  RMS.	  	  These	  findings	  reveal	  the	  crucial	  role	  of	  the	  ErbB4	  receptor	  present	  on	  neuroblasts	  and	  astrocytes	  as	  it	  helps	  regulate	  the	  formation	  and	  organizational	  structure	  of	  the	  RMS	  in	  vivo.	  	  Further	  investigation	  has	  revealed	  the	  NRG1	  type	  III	  isoform	  as	  the	  major	  ErbB4	  ligand	  acting	  in	  the	  RMS,	  especially	  in	  early	  postnatal	  stages	  [28].	  	  Localization	  studies	  of	  NRG1	  have	  found	  that	  there	  is	  almost	  complete	  overlap	  between	  NRG1	  staining	  and	  PSA-­‐NCAM	  positive	  neuroblasts	  suggesting	  that	  the	  NRG1	  ligand	  is	  expressed	  on	  migrating	  neuroblasts	  in	  the	  RMS	  [28].	  	  As	  a	  whole,	  the	  signaling	  cascade	  initiated	  by	  the	  binding	  of	  NRGs	  to	  ErbB4	  appears	  to	  be	  a	  crucial	  aspect	  of	  RMS	  development,	  but	  future	  research	  concerning	  the	  role	  of	  ErbB4	  signaling	  in	  cellular	  migration	  remains	  to	  be	  performed.	  	   In	  addition	  to	  Neuregulins,	  a	  class	  of	  axon	  guidance	  molecules	  known	  as	  Semaphorins	  have	  been	  shown	  to	  play	  a	  significant	  role	  in	  regulating	  neuronal	  migration	  by	  binding	  to	  Plexin	  receptors,	  which	  are	  divided	  into	  four	  subgroups	  (A-­‐D)	  [29].	  	  Research	  by	  Saha	  et	  al.	  has	  discovered	  that	  Plexin-­‐B2	  is	  highly	  expressed	  in	  Mash1-­‐positive	  transit	  amplifying	  progenitors	  (TAPs)	  and	  GFAP-­‐positive	  astrocytes	  in	  the	  SVZ	  [30].	  	  In	  the	  rostral	  migratory	  stream	  though,	  Plexin-­‐B2	  is	  found	  on	  migrating	  neuroblasts	  but	  absent	  on	  the	  surrounding	  astrocytes.	  	  Upon	  transitioning	  to	  radial	  migration	  in	  the	  OB,	  neuroblasts	  appear	  to	  downregulate	  Plexin-­‐B2	  expression,	  as	  it	  is	  not	  detectable	  in	  this	  population	  of	  cells	  [30].	  	  Interestingly,	  expression	  of	  Plexin-­‐B2	  does	  appear	  at	  lower	  levels	  in	  all	  olfactory	  axons,	  periglomerular	  cells,	  and	  mitral	  cells	  [30].	  	  In	  the	  RMS,	  granular	  cell	  layer,	  and	  mitral	  cell	  layer,	  class	  IV	  Semaphorins	  (Sema4A,	  4C,	  4D,	  and	  4G)	  act	  as	  ligands	  for	  Plexin-­‐B2,	  which	  reinforces	  the	  current	  belief	  that	  canonical	  Semaphorin-­‐Plexin	  signaling	  may	  act	  as	  a	  fine-­‐tuning	  mechanism	  for	  neuroblast	  migration	  at	  critical	  points	  during	  migration,	  such	  as	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the	  exit	  from	  the	  RMS	  and	  forming	  the	  layers	  of	  the	  olfactory	  bulb.	  	  Studies	  with	  Plxnb2	  knockout	  mice	  found	  an	  increase	  in	  aberrant	  neuroblast	  migration	  in	  non-­‐neurogenic	  regions	  such	  as	  the	  corpus	  callosum	  and	  the	  septum	  [30].	  	  Overall,	  Sema-­‐Plexin-­‐B2	  interactions	  are	  a	  crucial	  factor	  in	  cellular	  migration	  and	  neural	  development,	  especially	  in	  regulating	  neuroblast	  migration	  in	  the	  RMS.	  	   In	  addition	  to	  the	  extensive	  interactions	  between	  migrating	  neuroblasts	  and	  astrocytes	  in	  the	  developing	  RMS,	  the	  important	  role	  of	  vasculature	  in	  this	  brain	  region	  continues	  to	  gain	  support.	  	  Unlike	  the	  majority	  of	  the	  brain,	  which	  has	  a	  random	  distribution	  of	  blood	  vessels,	  it	  has	  been	  found	  that	  blood	  vessels	  develop	  in	  parallel	  to	  the	  RMS	  following	  birth	  [31].	  	  This	  ordered	  development	  of	  blood	  vessels	  is	  likely	  influenced	  by	  the	  secretion	  of	  the	  angiogenic	  factor	  VEGF	  at	  early	  postnatal	  stages	  by	  the	  astroglial	  network	  within	  the	  RMS.	  	  As	  expected,	  in	  vivo	  downregulation	  of	  VEGF	  expression	  in	  astrocytes	  caused	  angiogenesis	  at	  the	  outer	  border	  of	  the	  RMS	  to	  be	  altered,	  which	  led	  to	  aberrant	  neuroblast	  migration	  [32].	  	  Further	  evidence	  for	  the	  crucial	  role	  of	  vasculature	  in	  the	  RMS	  is	  the	  finding	  that	  neuroblasts	  migrate	  more	  efficiently	  when	  in	  intimate	  contact	  with	  the	  vasculature	  scaffold	  of	  the	  RMS,	  which	  is	  further	  reinforced	  by	  the	  increased	  speed	  of	  neuroblast	  migration	  in	  adult	  mice	  in	  comparison	  to	  early	  postnatal	  stages	  when	  the	  vasculature	  network	  is	  less	  developed.	  	  Interestingly,	  a	  unique	  relationship	  has	  been	  revealed	  between	  astrocytes,	  blood	  vessels,	  and	  migrating	  neuroblasts	  in	  which	  the	  astroglial	  network	  promotes	  blood	  vessel	  development	  through	  VEGF	  signaling	  [32]	  while	  endothelial	  cells	  secrete	  BDNF,	  which	  promotes	  neuroblast	  migration	  through	  p75NTR	  activity	  in	  the	  neuroblast	  population	  [31].	  	  Despite	  these	  advances	  in	  understanding	  the	  complex	  interactions	  between	  vasculature	  and	  the	  cellular	  subpopulations	  of	  the	  RMS,	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much	  research	  remains	  to	  fully	  elucidate	  their	  role	  in	  the	  development	  and	  proper	  functioning	  of	  the	  RMS.	  	   Essential	  to	  the	  crosstalk	  between	  migrating	  neuroblasts	  and	  the	  astrocytes	  of	  the	  RMS	  glial	  tubes	  is	  the	  Eph	  family	  of	  receptors	  and	  their	  transmembrane-­‐associated	  ligands	  known	  as	  ephrins.	  	  Ephs	  are	  transmembrane	  tyrosine	  kinase	  receptors	  that	  bind	  to	  ephrin	  ligands,	  which	  are	  either	  transmembrane	  (ephrin-­‐Bs)	  or	  tethered	  to	  the	  membrane	  by	  a	  GPI	  tail	  (ephrin-­‐As)	  [32].	  	  Eph/ephrin	  signaling	  is	  crucial	  during	  development,	  as	  it	  has	  been	  to	  linked	  to	  the	  regulation	  of	  axon	  guidance	  and	  neural	  crest	  cell	  migration	  [34].	  	  Research	  has	  elucidated	  two	  modes	  of	  signaling	  involving	  Ephs	  and	  ephrins:	  the	  ‘classic’	  mode	  of	  signaling	  (forward	  signaling)	  is	  from	  ephrin	  ligands	  to	  their	  Eph	  receptors	  and	  typically	  results	  in	  cellular	  repulsion,	  while	  reverse	  signaling	  occurs	  from	  Eph	  receptors	  to	  ephrins	  and	  has	  been	  found	  to	  promote	  adhesion	  [33].	  	  In	  regards	  to	  the	  development	  of	  the	  RMS,	  it	  has	  been	  noted	  that	  ephrin	  B2	  and	  B3	  ligands	  are	  located	  on	  astrocytes	  in	  the	  SVZ/RMS	  and	  the	  olfactory	  bulb.	  	  In	  addition,	  the	  disruption	  of	  normal	  EphB/ephrin-­‐B	  signaling	  due	  to	  the	  infusion	  of	  truncated	  EphB2	  and	  ephrin-­‐B2	  proteins	  into	  the	  lateral	  ventricle	  results	  in	  increased	  cellular	  proliferation	  in	  the	  SVZ	  and	  also	  disrupts	  neuroblast	  chain	  migration	  [35].	  	  Overall,	  current	  research	  holds	  that	  ephrins	  are	  located	  on	  astrocytes	  in	  the	  SVZ	  and	  along	  the	  RMS	  and	  interact	  with	  the	  ephrin	  receptors	  EphA4,	  EphB1,	  and	  EphB2	  along	  the	  RMS	  neuroblast	  migratory	  pathway.	  	  Currently,	  the	  exact	  location	  of	  these	  ephrin	  receptors	  in	  the	  developing	  RMS	  remains	  unknown,	  forcing	  a	  debate	  on	  whether	  they	  are	  present	  on	  astrocytes,	  neuroblasts,	  or	  both.	  	  In	  addition,	  it	  remains	  to	  be	  determined	  whether	  the	  disruption	  of	  proper	  neuroblast	  migration	  following	  changes	  in	  Eph/ephrin	  signaling	  is	  solely	  due	  to	  changes	  in	  astrocyte-­‐neuroblast	  crosstalk	  or	  if	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abnormal	  proliferation	  due	  to	  the	  disruption	  of	  ephrin	  signaling	  in	  the	  SVZ	  also	  plays	  a	  role.	  	  Despite	  recent	  advances	  in	  understanding	  cellular	  migration	  and	  Eph/ephrin	  signaling,	  much	  research	  remains	  to	  translate	  these	  findings	  to	  glial	  tube	  formation	  and	  neuroblast	  migration	  in	  the	  developing	  rostral	  migratory	  stream.	  	   One	  Eph	  tyrosine	  kinase	  receptor	  that	  appears	  to	  be	  highly	  relevant	  in	  cellular	  migration	  and	  boundary	  formation	  is	  EphA4,	  which	  has	  the	  unique	  ability	  to	  bind	  ephrinB2	  and	  ephrinB3	  in	  addition	  to	  ephrinAs,	  consequently	  facilitating	  bidirectional	  signaling	  [36].	  	  Research	  by	  Conover	  et	  al.	  has	  detected	  EphA4	  within	  the	  SVZ,	  subsequently	  driving	  additional	  research	  to	  explore	  its	  potential	  role	  in	  regulating	  neuroblast	  migration	  and	  glial	  tube	  formation	  in	  the	  RMS	  [35].	  	  Research	  by	  previous	  and	  current	  graduate	  students,	  in	  addition	  to	  my	  research	  as	  an	  undergraduate,	  has	  found	  EphA4	  to	  be	  expressed	  in	  the	  SVZ	  and	  RMS	  where	  it	  acts	  to	  orient	  astrocytes	  into	  a	  complex	  astroglial	  meshwork	  around	  migrating	  neuroblasts.	  	  As	  a	  result,	  the	  EphA4-­‐dependent	  formation	  of	  this	  astrocyte	  framework	  establishes	  a	  specific	  and	  well-­‐defined	  pathway	  for	  neuroblast	  migration	  from	  the	  SVZ	  to	  the	  OB.	  	  	  As	  a	  whole,	  my	  undergraduate	  research	  at	  the	  University	  of	  Connecticut	  was	  aimed	  at	  elucidating	  astrocyte	  infiltration	  and	  proliferation	  within	  the	  developing	  RMS	  and	  to	  compare	  RMS	  astrocyte	  morphology/phenotype	  to	  glial	  scar	  astrocyte	  morphology/phenotype.	  	  In	  addition	  to	  this	  research,	  I	  continued	  to	  explore	  the	  RMS	  developmental	  paradigm	  by	  building	  upon	  the	  research	  of	  current	  and	  past	  graduate	  students	  on	  the	  critical	  role	  of	  EphA4	  in	  glial	  tube	  formation	  in	  the	  developing	  RMS.	  	  As	  a	  result,	  research	  by	  Dr.	  Conover’s	  lab	  has	  found	  that	  disruption	  of	  EphA4	  signaling	  leads	  to	  improper	  glial	  tube	  formation	  and	  irregular	  neuroblast	  migration.	  	  Our	  research	  has	  also	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utilized	  MACS	  and	  MACS/FACS	  techniques	  to	  investigate	  the	  cell-­‐specific	  location	  of	  EphA4,	  while	  also	  employing	  BrdU	  labeling	  to	  explore	  its	  possible	  role	  in	  regulating	  cellular	  proliferation	  in	  the	  SVZ	  and	  RMS.	  	  
Materials	  and	  Methods:	  Animals:	  Male	  and	  female	  EphA4,	  EphA4ΔeGFP/ΔeGFP,	  and	  hGFAP:mRFP	  mice	  were	  bred	  and	  aged	  in	  Dr.	  Joanne	  Conover’s	  vivarium	  at	  the	  University	  of	  Connecticut.	  	  Animal	  procedures	  were	  performed	  under	  protocols	  approved	  by	  the	  Institutional	  Animal	  Care	  and	  Use	  Committee	  (IACUC)	  of	  the	  University	  of	  Connecticut	  and	  conform	  to	  the	  National	  Institute	  of	  Health	  and	  Association	  for	  Assessment	  and	  Accreditation	  of	  Laboratory	  Animal	  Care	  guidelines.	  	  	  	  Immunohistochemistry:	  	   EphA4	  mice	  were	  perfused	  transcardially	  with	  0.9%	  saline	  followed	  by	  4%	  paraformaldehyde	  in	  pH	  7.4	  phosphate	  buffered	  saline	  (PBS).	  	  Following	  perfusion,	  brains	  were	  removed	  from	  the	  mice	  and	  fixed	  overnight	  in	  a	  4°C	  cold	  room	  in	  4%	  paraformaldehyde	  in	  pH	  7.4	  PBS.	  	  Brains	  were	  then	  washed	  in	  PBS	  on	  a	  shaker	  table	  at	  room	  temperature	  three	  times	  for	  40	  minutes	  each.	  	  Brains	  were	  sectioned	  into	  40-­‐50	  μm	  slices	  with	  a	  vibratome	  (VT-­‐1000s,	  Leica,	  Wetzlar,	  Germany)	  and	  ordered	  into	  PBS-­‐filled	  wells	  with	  extreme	  care	  to	  maintain	  the	  order	  of	  the	  serial	  sections.	  	  The	  tissue	  was	  then	  washed	  with	  PBS,	  blocked	  with	  10%	  horse	  serum	  in	  PBS-­‐0.1%	  Triton,	  and	  incubated	  with	  primary	  antibody	  (varied	  depending	  on	  specific	  experiment;	  included	  rat	  anti	  BrdU,	  rabbit	  anti	  GFAP,	  goat	  anti	  DCX,	  etc…)	  overnight	  on	  a	  shaker	  table	  in	  a	  4°C	  cold	  room.	  	  Primary	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antibody	  solution	  was	  removed	  and	  the	  brains	  were	  then	  washed	  with	  PBS	  three	  times	  for	  ten	  minutes	  each	  at	  room	  temperature.	  	  Alexa	  Fluor	  dye-­‐conjugated	  secondary	  antibodies	  (varied	  depending	  on	  experiment;	  included	  donkey	  anti	  rat	  488,	  donkey	  anti	  rabbit	  546,	  donkey	  anti	  goat	  546,	  donkey	  anti	  rabbit	  647,	  etc…)	  were	  then	  applied	  to	  the	  tissue	  for	  one	  hour	  at	  room	  temperature	  on	  the	  shaker	  table.	  	  Brain	  sections	  were	  washed	  in	  PBS	  three	  times	  for	  10	  minutes	  each	  at	  room	  temperature	  on	  the	  shaker	  table	  and	  then	  mounted	  from	  PBS	  on	  slides.	  	  Coverslips	  were	  fixed	  on	  the	  slides	  using	  Aquapolymount	  and	  allowed	  to	  dry.	  	  Brain	  sections	  were	  then	  imaged	  and	  analyzed.	  	  	  	  	  	  RMS	  Area	  Measurements:	  	   Kasey	  Baker	  sliced	  coronal	  brain	  sections	  at	  50	  μm	  and	  labeled	  the	  brain	  sections	  with	  DCX	  and	  GFAP.	  	  Following	  labeling,	  fluorescent	  images	  of	  the	  RMS	  were	  acquired	  (Axioskop	  2+,	  Zeiss;	  Retiga	  EX,	  Q-­‐Imaging	  System)	  at	  3.67,	  3.72,	  and	  3.77	  mm	  distal	  to	  the	  beginning	  of	  the	  OBs.	  	  Sample	  size	  for	  each	  group	  was	  at	  least	  three	  animals.	  	  The	  DCX+	  areas	  were	  measured	  using	  Openlab	  3.1.5	  (Improvision,	  Lexington,	  MA).	  	  Mean	  values	  and	  ±SEM	  were	  then	  calculated.	  	  Student’s	  t-­‐test	  was	  used	  for	  statistical	  analysis	  (*P<0.05,	  **P<0.001).	  	  	  	  BrdU	  Immunohistochemistry:	  	   Mice	  were	  given	  an	  intraperitoneal	  injection	  with	  300	  mg	  BrdU/kg	  two	  hours	  prior	  to	  animal	  sacrifice	  and	  perfusion	  [37].	  	  BrdU	  immunostaining	  of	  40	  μm	  sections	  was	  performed	  as	  described	  by	  Cameron	  and	  McKay	  (2001)	  [37].	  	  Sections	  were	  imaged	  (Axioskop	  2+,	  Zeiss)	  and	  the	  BrdU+	  cells	  were	  counted	  in	  coronal	  sections	  of	  the	  SVZ	  and	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the	  RMS	  using	  ImageJ	  imaging	  software	  (National	  Institutes	  of	  Health,	  Bethesda,	  MD).	  	  SVZ	  sections	  (40μm)	  were	  analyzed	  from	  coordinates	  1.70	  mm	  bregma,	  5.50	  mm	  interaural	  to	  0.00	  mm	  bregma,	  3.80	  mm	  interaural	  and	  RMS	  sections	  (40	  μm)	  were	  analyzed	  from	  coordinates	  2.71	  mm	  bregma,	  6.51	  mm	  interaural	  to	  1.98	  mm	  bregma,	  5.78	  mm	  interaural.	  	  Number	  of	  mice	  varied	  for	  each	  group	  (see	  Results).	  	  Sections	  were	  labeled	  with	  anti-­‐BrdU,	  anti-­‐DCX,	  and	  anti-­‐GFAP.	  	   	  BrdU/EdU	  Pulse	  Labeling:	  	   EphA4	  WT	  mice	  (first	  experiment)	  were	  administered	  a	  150	  mg	  BrdU/kg	  IP	  injection	  at	  three	  days	  of	  age	  (P3).	  	  At	  P5,	  the	  same	  mice	  were	  given	  an	  IP	  injection	  of	  150	  mg	  EdU/kg	  two	  hours	  prior	  to	  animal	  sacrifice	  and	  perfusion.	  	  BrdU	  immunostaining	  of	  40	  μm	  sections	  was	  performed	  as	  described	  by	  Cameron	  and	  McKay	  (2001).	  	  EdU	  immunostaining	  of	  the	  same	  sections	  was	  performed	  as	  described	  by	  the	  Click-­‐iT®	  Plus	  EdU	  Imaging	  Kits	  protocol	  published	  by	  Life	  Technologies™.	  	  Sections	  were	  imaged	  with	  a	  Leica	  TCS	  SP2	  confocal	  system	  together	  with	  a	  Leica	  DMIRE2	  microscope	  and	  Leica	  confocal	  software	  (Leica	  Microsystems,	  Wetzlar/Marburg,	  Germany).	  	  Sections	  were	  labeled	  with	  anti-­‐BrdU,	  anti-­‐EdU,	  and	  anti-­‐GFAP.	  	  An	  additional	  experiment	  was	  performed	  using	  hGFAP:mRFP	  mice	  following	  the	  same	  procedure	  to	  more	  clearly	  label	  astrocytes	  within	  the	  developing	  RMS.	  	  A	  third	  experiment	  using	  hGFAP:mRFP	  mice	  was	  conducted	  using	  a	  chase	  period	  of	  10	  days	  to	  provide	  additional	  time	  for	  dividing	  neuroblasts	  to	  escape	  the	  region,	  ultimately	  highlighting	  the	  proliferating	  astrocytes	  that	  remained.	  	  Preliminary	  results	  were	  obtained	  by	  analyzing	  three	  RMS	  sections	  from	  2.34	  mm	  bregma,	  6.14	  mm	  interaural	  to	  2.22	  mm	  bregma,	  6.02	  mm	  interaural	  from	  three	  WT	  brains.	  	  Total	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BrdU+/GFAP+,	  EdU+/GFAP+,	  and	  BrdU+/EdU+/GFAP+	  cells	  inside	  and	  outside	  the	  RMS	  were	  counted.	  	  	  	  MACS/FACS	  Cell	  Enrichment	  and	  Sorting:	  	   P3-­‐P12	  EphA4ΔeGFP/ΔeGFP	  and	  EphA4	  WT	  (negative	  control)	  mice	  brains	  were	  dissected	  under	  cold	  DMEM,	  and	  the	  regions	  of	  interest	  were	  removed.	  	  The	  brain	  regions	  of	  interest	  were	  mechanically	  dissociated	  using	  forceps.	  	  Following	  mechanical	  dissociation,	  0.025%	  trypsin	  was	  added	  to	  the	  tissue	  and	  then	  triturated	  using	  a	  1000	  μL	  filter-­‐tipped	  pipet.	  	  The	  samples	  were	  then	  incubated	  for	  20	  minutes	  at	  37°C	  with	  gentle	  shaking	  to	  facilitate	  dissociation.	  	  Following	  incubation,	  the	  samples	  were	  centrifuged	  at	  350xg	  for	  three	  to	  five	  minutes,	  and	  supernatant	  was	  aspirated.	  	  The	  resulting	  pellet	  was	  resuspended	  in	  2-­‐7	  mL	  10%	  FBS	  in	  DMEM	  to	  neutralize	  the	  trypsin	  previously	  added	  to	  the	  solution.	  	  Solution	  was	  then	  filtered	  through	  70μm	  cell	  strainer	  and	  collected.	  	  The	  resulting	  samples	  were	  centrifuged	  for	  five	  minutes	  at	  350xg,	  and	  supernatant	  was	  removed.	  	  To	  perform	  MACS	  enrichment	  for	  neuroblasts,	  the	  pellet	  was	  resuspended	  in	  ice-­‐cold	  0.5%	  BSA	  in	  PBS	  (“buffer”).	  	  Solutions	  were	  aspirated	  into	  2	  mL	  eppendorf	  tubes	  (70-­‐80	  μL/sample)	  and	  incubated	  for	  10	  minutes	  at	  4°C.	  	  To	  deplete	  cells	  with	  the	  A2B5	  antigen	  (removal	  of	  glial	  progenitors),	  MACS	  antibodies	  (anti-­‐A2B5	  mouse	  IgM)	  and	  Anti-­‐Mouse	  IgM	  Microbeads	  were	  added,	  and	  the	  solutions	  were	  incubated	  for	  10-­‐15	  minutes	  at	  4°C.	  	  Samples	  were	  rinsed	  in	  1-­‐2	  mL	  buffer,	  centrifuged,	  and	  supernatant	  was	  aspirated.	  	  The	  resulting	  pellets	  were	  resuspended	  in	  buffer.	  	  Secondary	  antibody	  incubation	  was	  then	  performed	  for	  GLAST	  enrichment	  and	  the	  resulting	  samples	  were	  rinsed	  in	  1-­‐2	  mL	  buffer,	  centrifuged,	  and	  supernatant	  was	  aspirated.	  	  The	  resulting	  pellets	  were	  resuspended	  in	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buffer.	  	  MACS	  columns	  were	  prepared	  by	  setting	  up	  the	  magnet	  and	  then	  loading	  with	  500μL	  ice-­‐cold	  buffer,	  which	  was	  allowed	  to	  elute.	  	  500	  μL	  of	  sample	  was	  loaded	  onto	  each	  column	  and	  3x500	  μL	  ice-­‐cold	  buffer	  was	  added	  to	  each	  column	  to	  rinse	  after	  each	  time	  it	  emptied.	  	  Flow-­‐through	  was	  collected	  for	  analysis.	  	  The	  column	  was	  then	  removed	  and	  the	  sample	  was	  eluted	  with	  500	  μL	  cold	  PBS	  or	  5%	  serum	  in	  PBS	  (Concentration	  of	  samples	  should	  be	  below	  106	  cells/mL).	  	  For	  FACS,	  1	  μL	  Alexa-­‐fluor-­‐conjugated	  antibody	  was	  added	  and	  then	  incubated	  with	  gentle	  agitation	  for	  at	  least	  20	  minutes	  at	  room	  temperature.	  	  Cells	  were	  rinsed	  in	  1	  mL	  PBS,	  centrifuged,	  and	  supernatant	  was	  aspirated.	  	  Cells	  were	  then	  resuspended	  in	  500	  μL	  PBS	  and	  placed	  on	  ice.	  	  Labeled,	  unlabeled,	  or	  flow-­‐through	  populations	  were	  sorted	  by	  FACS	  at	  the	  flow	  cytometry	  core.	  	  The	  FACS-­‐sorted	  cell	  populations	  were	  then	  identified	  as	  neuroblasts,	  astrocytes,	  or	  endothelial	  cells	  based	  on	  comparative	  transcriptional	  analysis	  via	  qRT-­‐PCR	  or	  by	  immunocytochemistry	  antibody	  labeling	  for	  cell-­‐type	  specific	  proteins.	  	  Due	  to	  complications	  that	  arose	  in	  preliminary	  cell	  sorting	  methods,	  additional	  analysis	  required	  the	  cells	  to	  be	  fixed	  and	  permeabilized	  using	  1%	  PFA	  and	  0.1%	  Tx,	  2%	  serum	  in	  PBS,	  which	  allowed	  the	  cells	  to	  be	  labeled	  using	  anti-­‐GFP.	  	  Following	  this	  step,	  flow	  cytometry	  was	  performed	  using	  the	  same	  machine	  described	  previously.	  	  qRT-­‐PCR:	  	   Following	  MACS-­‐FACS,	  qRT-­‐PCR	  was	  performed	  on	  cell	  populations	  according	  to	  Life	  Technologies’™	  SuperScript™	  III	  First-­‐Strand	  Synthesis	  System	  for	  RT-­‐PCR	  protocol	  and	  BIO-­‐RAD’s	  iTaq™	  Universal	  SYBR	  Green	  Supermix	  protocol.	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Results:	  
Astrocyte	  Proliferation	  and	  Infiltration	  into	  the	  Neuroblast-­Dense	  RMS	  	   A	  hallmark	  of	  my	  undergraduate	  research	  at	  the	  University	  of	  Connecticut	  was	  focused	  on	  investigating	  the	  developmental	  time	  course	  of	  astrocyte	  invasion	  into	  the	  RMS	  of	  mice.	  	  In	  addition,	  a	  central	  question	  concerning	  this	  developmental	  phenomenon	  focuses	  on	  the	  proliferative	  capacity	  of	  invading	  astrocytes.	  	  In	  other	  words,	  I	  questioned	  whether	  astrocytes	  continue	  to	  divide	  during	  and/or	  after	  RMS	  glial	  tube	  formation	  or	  if	  these	  cells	  only	  divide	  outside	  of	  this	  region	  and	  subsequently	  invade	  and	  reorient	  in	  the	  RMS	  without	  any	  further	  division.	  	  Currently,	  it	  has	  been	  found	  that	  few	  astrocytes	  are	  present	  in	  the	  RMS	  core	  at	  P3	  despite	  the	  large	  population	  of	  these	  cells	  densely	  surrounding	  this	  region	  at	  this	  time	  point.	  	  By	  P5,	  immunohistochemistry	  (IHC)	  studies	  have	  revealed	  that	  numerous	  astrocytes	  begin	  to	  invade	  and	  populate	  the	  developing	  RMS	  and	  form	  highly	  organized	  glial	  tubes.	  Additional	  IHC	  studies	  demonstrated	  that	  this	  phenomenon	  occurs	  through	  P16.	  	  The	  specific	  mechanism(s)	  for	  astrocyte	  infiltration	  and	  orientation	  within	  the	  RMS	  remain	  to	  be	  determined	  although	  and	  likely	  include	  signaling	  through	  Eph-­‐ephrin	  interactions,	  which	  have	  been	  found	  to	  mediate	  cellular	  repulsion	  and	  adhesion	  in	  the	  developing	  nervous	  system.	  	  To	  address	  the	  temporal	  and	  spatial	  dynamics	  of	  astrocyte	  proliferation	  in	  the	  developing	  RMS,	  an	  experimental	  paradigm	  employing	  dual-­‐pulse	  labeling	  with	  thymidine	  analogs	  was	  used.	  	  To	  be	  more	  specific,	  acute	  injections	  (150	  mg/kg)	  of	  the	  proliferation	  markers	  5-­‐bromo-­‐2’-­‐deoxyuridine	  (BrdU)	  and	  5-­‐ethynyl-­‐2’-­‐deoxuridine	  (EdU)	  were	  administered	  based	  on	  a	  specific	  experimental	  schedule	  highlighted	  in	  Figure	  2a.	  	  Administration	  of	  BrdU	  at	  P3	  was	  performed	  to	  label	  dividing	  astrocytes	  outside	  of	  the	  RMS,	  while	  the	  administration	  of	  EdU	  at	  P5/6	  was	  employed	  to	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label	  proliferating	  astrocytes	  within	  the	  RMS	  during	  development.	  	  BrdU/EdU	  tissue	  collected	  was	  also	  processed	  with	  GFAP	  antibodies	  to	  highlight	  astrocytes	  in	  this	  developing	  region.	  	  Administration	  of	  BrdU	  at	  P3	  revealed	  a	  very	  small	  population	  of	  dividing	  astrocytes	  in	  the	  area	  surrounding	  the	  RMS.	  	  In	  addition,	  no	  BrdU+/GFAP+	  double-­‐labeled	  cells	  were	  found	  within	  the	  RMS	  core,	  indicating	  astrocyte	  division	  does	  not	  occur	  within	  the	  RMS	  at	  this	  time	  point.	  	  Following	  the	  administration	  of	  EdU	  at	  P5,	  IHC	  analysis	  revealed	  similar	  findings,	  with	  a	  reduced	  number	  of	  EdU+/GFAP+	  double-­‐labeled	  cells	  in	  the	  region	  surrounding	  the	  RMS	  and	  very	  few	  EdU+/GFAP+	  cells	  within	  the	  core	  of	  the	  RMS.	  	  Triple-­‐labeled	  BrdU+/EdU+/GFAP+	  cells	  were	  also	  very	  rare;	  a	  low	  number	  were	  found	  in	  the	  region	  surrounding	  the	  RMS	  and	  none	  were	  observed	  within	  (Figure	  2b).	  	  As	  a	  result,	  these	  experiments	  suggest	  that	  the	  increased	  number	  of	  astrocytes	  within	  the	  core	  of	  the	  early	  postnatal	  RMS	  results	  from	  the	  infiltration	  of	  proliferating	  astrocytes	  from	  the	  surrounding	  tissue.	  	  These	  experiments	  also	  address	  the	  question	  of	  astrocyte	  proliferation	  and	  infiltration	  by	  indicating	  that	  RMS	  astrocytes	  do	  not	  typically	  divide	  after	  forming	  glial	  tubes	  within	  this	  region.	  	  Instead,	  it	  is	  appears	  that	  astrocytes	  divide	  in	  order	  to	  form,	  or	  while	  forming,	  glial	  tubes.	  	  Subsequent	  experimentation	  employing	  the	  same	  experimental	  schedule	  with	  transgenic	  GFAP:mRFP1	  reporter	  mice	  used	  to	  aid	  in	  the	  visualization	  of	  nuclear	  proliferation	  markers	  has	  revealed	  similar	  findings	  (Figure	  3).	  	  To	  further	  strengthen	  my	  findings,	  I	  performed	  an	  additional	  experiment	  in	  which	  the	  chase	  period	  for	  EdU	  administration	  was	  10	  days,	  which	  provided	  additional	  time	  for	  proliferating	  neuroblasts	  to	  exit	  the	  region.	  	  In	  doing	  so,	  I	  was	  able	  to	  visualize	  proliferating	  astrocytes	  in	  the	  developing	  RMS	  with	  reduced	  interference	  from	  BrdU	  and	  EdU	  labeling	  of	  dividing	  neuroblasts.	  	  Preliminary	  results,	  in	  which	  total	  BrdU+/GFAP+,	  EdU+/GFAP+,	  and	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BrdU+/EdU+/GFAP+	  cells	  inside	  and	  outside	  the	  RMS	  were	  counted,	  further	  reinforce	  the	  findings	  from	  the	  previous	  two	  experiments	  in	  which	  a	  greater	  number	  of	  triple-­‐labeled	  cells	  were	  found	  outside	  of	  the	  RMS	  (Figure	  4).	  	  Interestingly	  though,	  an	  increased	  number	  of	  EdU+/GFAP+	  cells	  were	  found	  within	  the	  RMS	  using	  this	  experimental	  schedule,	  suggesting	  that	  division	  of	  astrocytes	  may	  occur	  within	  the	  RMS	  following	  invasion	  from	  the	  periphery.	  	  As	  a	  result,	  subsequent	  experimentation	  employing	  different	  pulse-­‐chase	  time	  points	  will	  be	  performed	  in	  future	  studies.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	  2.	  	  BrdU	  and	  EdU	  Pulse-­Labeling	  to	  Investigate	  Astrocyte	  Proliferative	  
Capacity	   in	   the	   Early	   RMS.	   (A)	   Diagram	   of	   initial	   dual-­‐pulse	   labeling	   of	  proliferative	   S-­‐phase	   cells	   within	   the	   anterior	   forebrain	   using	   the	   thymidine	  analogues	   BrdU	   and	   EdU.	   	   (B).	   	   Fluorescence	   microscopy	   of	   astrocyte	  proliferation	   in	   the	   region	   surrounding	   the	   RMS	   indicating	   a	   BrdU+/EdU+	  proliferating	   GFAP+	   cell	   within	   the	   tissue	   directly	   neighboring	   the	   developing	  RMS.	   	  Asterisk	  denotes	  the	  RMS,	  and	   its	  boundary	   is	  marked	  by	  the	  dotted	   line.	  	  Arrowhead	  marks	  a	  BrdU+/EdU+/GFAP+	  tripled-­‐labeled	  cell.	  	  Scale	  bar	  50	  μm.	  
Figure	  3.	   	  BrdU	  and	  EdU	  Pulse-­Labeling	   in	  hGFAP:mRFP	  Mice.	   	  Fluorescence	  microscopy	  of	  astrocyte	  proliferation	  within	  the	  RMS	  indicating	  a	  RFP+	  cell	  that	  is	  BrdU+	  but	  not	  EdU+,	  suggesting	  a	  lack	  of	  multiple	  divisions.	  	  Arrowhead	  marks	  a	  BrdU+/RFP+	  cell.	  	  The	  boundary	  of	  the	  RMS	  is	  marked	  by	  the	  dashed	  line.	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Astrocyte	  Morphology	  in	  the	  Rostral	  Migratory	  Stream	  Resembles	  Reactive	  Astrogliosis	  	   While	  investigating	  astrocyte	  proliferation	  and	  infiltration	  in	  the	  developing	  RMS,	  it	  was	  noted	  that	  invading	  astrocytes	  in	  the	  RMS	  have	  distinct	  morphological	  features	  that	  strongly	  resemble	  reactive	  astrocytes,	  which	  play	  a	  crucial	  role	  in	  the	  formation	  of	  glial	  scars	  following	  CNS	  injury	  [38,	  39].	  	  To	  further	  investigate	  this	  initial	  observation,	  tissue	  samples	  were	  collected	  and	  analyzed	  using	  GFAP	  antibodies	  to	  visualize	  astrocyte	  morphology.	  	  In	  doing	  so,	  representative	  images	  of	  protoplasmic,	  fibrous,	  reactive,	  and	  RMS	  astrocytes	  were	  processed	  for	  initial	  comparison	  (Figure	  5).	  	  Analysis	  of	  the	  representative	  images	  collected	  further	  reinforced	  the	  similarities	  between	  RMS	  and	  reactive	  astrocytes	  as	  
Figure	   4.	   	   BrdU+,	   EdU+,	   and	   GFAP+	   Total	   Cell	   Counts	   from	   the	   RMS	   of	  
hGFAP:mRFP	   Mice.	   	   Total	   cell	   counts	   of	   BrdU+/GFAP+,	   EdU+/GFAP+,	   and	  BrdU+/EdU+/GFAP+	  cells	   inside	  and	  outside	   the	  RMS	  were	  counted	   from	  3	  RMS	  sections	  from	  3	  WT	  hGFAP:mRFP	  mice	  (9	  sections	  in	  total).	  	  As	  expected,	  the	  total	  number	  of	  BrdU+/EdU+/GFAP+	  cells	  inside	  the	  RMS	  was	  much	  less	  than	  the	  total	  number	   of	   these	   triple-­‐labeled	   cells	   outside	   the	   RMS.	   	   Blue	   brackets	   highlight	  triple-­‐labeled	  cells	  inside	  and	  outside	  the	  RMS.	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both	  cell	  populations	  exhibit	  hypertrophic	  fibrous	  processes	  and	  increased	  cellular	  packing	  density.	  	  Subsequent	  research	  will	  investigate	  astrocyte	  morphology	  at	  P3,	  P5,	  P7,	  P10,	  P12	  in	  a	  minimum	  of	  n=3	  mice	  per	  timepoint	  using	  IHC.	  	  Quantitative	  real-­‐time	  polymerase	  chain	  reaction	  (qRT-­‐PCR)	  against	  TGFβ,	  AQP4,	  nestin,	  and	  GFAPδ,	  which	  have	  been	  shown	  to	  be	  upregulated	  in	  glial	  scarring,	  will	  be	  used	  for	  transcriptional	  analysis	  of	  RMS	  and	  reactive	  astrocytes	  [39,	  40,	  41].	  	  GFAP:mRFP1	  mice	  will	  also	  be	  used	  to	  aid	  in	  the	  visualization	  of	  reactive	  and	  RMS	  astrocytes	  and	  in	  fluorescence-­‐activated	  cell	  sorting	  (FACS)	  for	  transcriptional	  analysis	  of	  these	  cell	  populations.	  	  Findings	  from	  preliminary	  data	  and	  future	  studies	  concerning	  glial	  tube	  astrocyte	  morphology	  and	  reactive	  astrogliosis	  will	  hopefully	  increase	  our	  current	  understanding	  of	  glial	  scar	  formation	  following	  CNS	  injury	  and	  subsequently	  lead	  to	  the	  development	  of	  novel	  therapies	  to	  control	  glial	  scarring.	  	   	  	  	  	  	  	  	  	  	  	   	  	  	   	  	   	  	  
	  
	  
Figure	  5.	  Astrocyte	  Morphology	  in	  the	  Brain.	  	  GFAP	  immunoreactivity	  of	  (A)	  protoplasmic	  astrocytes	   found	   in	   the	   cortex,	   (B)	   fibrous	   astrocytes	   present	   in	   the	   corpus	   callosum,	   (C)	  reactive	  astrocytes	  resulting	  from	  a	  cortical	  stab	   injury,	  and	  (D)	  glial	   tube	  astrocytes	   from	  the	   rostral	   migratory	   stream.	   	   Similar	   features	   are	   shared	   between	   reactive	   and	   RMS	  astrocytes,	  including	  hypertrophic	  fibrous	  processes	  and	  increased	  cellular	  packing	  density.	  	  Scale	  bar	  50	  μm.	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EphA4	  Plays	  a	  Crucial	  Role	  in	  Glial	  Tube	  Formation	  and	  Neuroblast	  Restriction	  in	  the	  RMS	  	   Currently,	  little	  research	  has	  investigated	  the	  molecular	  and	  cellular	  mechanisms	  involved	  in	  the	  arrangement	  of	  astrocytic	  processes	  into	  RMS	  glial	  tubes	  in	  early	  postnatal	  development.	  	  We	  hypothesize	  that	  the	  early	  development	  of	  the	  RMS	  is	  dependent	  on	  molecular	  signaling	  mechanisms	  similar	  to	  reactive	  astrogliosis.	  	  For	  instance,	  one	  critical	  member	  of	  the	  Eph	  family	  of	  tyrosine	  kinase	  receptors,	  EphA4,	  has	  been	  found	  on	  reactive	  astrocytes,	  but	  its	  role	  in	  the	  formation	  of	  glial	  scars	  remains	  to	  be	  determined	  [43-­‐46].	  	  In	  addition	  to	  glial	  scarring,	  a	  more	  comprehensive	  investigation	  of	  EphA4	  and	  its	  role	  in	  glial	  tube	  formation	  and	  regulation	  in	  the	  postnatal	  and	  adult	  forebrain	  is	  crucial	  for	  a	  greater	  understanding	  of	  cellular	  migration	  and	  cell-­‐cell	  contact-­‐mediated	  interactions.	  	   To	  first	  investigate	  the	  role	  of	  EphA4	  in	  RMS	  development,	  cytoarchitectural	  morphology	  of	  transgenic	  EphA4-­‐/-­‐	  and	  wild-­‐type	  (WT)	  mice	  was	  analyzed	  at	  P6	  and	  P12	  (Figure	  6).	  	  At	  the	  P6	  time	  point,	  few	  differences	  were	  found	  between	  the	  two	  mouse	  strains.	  GFAP+	  astrocytes	  from	  the	  surrounding	  tissue	  had	  begun	  to	  invade	  the	  RMS	  core	  and	  blood	  vessel	  development	  appeared	  to	  occur	  in	  a	  parallel	  fashion	  to	  the	  RMS.	  	  DCX+	  neuroblasts	  also	  participated	  in	  tangential	  chain	  migration	  in	  EphA4-­‐/-­‐	  and	  WT	  mice	  at	  P6.	  	  By	  P12	  though,	  changes	  in	  RMS	  structure	  between	  EphA4-­‐/-­‐	  and	  WT	  mice	  became	  much	  more	  apparent.	  	  In	  WT	  mice,	  it	  was	  observed	  that	  astrocytes	  within	  the	  RMS	  core	  were	  oriented	  in	  a	  parallel	  fashion	  to	  neuroblast	  migration,	  essentially	  forming	  a	  defined	  astroglial	  meshwork	  that	  enclosed	  the	  migrating	  neuroblasts.	  	  In	  the	  KO	  mouse	  though,	  astrocyte	  morphology	  and	  orientation	  appeared	  greatly	  changed,	  as	  hypertrophic	  and	  disorganized	  astrocytes	  were	  found	  within	  the	  RMS	  core.	  	  The	  restriction	  of	  neuroblasts	  to	  the	  RMS	  was	  also	  disturbed	  in	  EphA4-­‐/-­‐	  mice	  as	  neuroblasts	  were	  noted	  to	  extend	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processes	  radially	  and	  escape	  from	  the	  RMS.	  	  This	  was	  not	  found	  in	  WT	  mice,	  as	  neuroblasts	  appeared	  to	  be	  highly	  restricted	  within	  the	  developing	  RMS,	  which	  is	  shown	  through	  DCX	  IHC	  (red	  dotted	  line	  in	  Figure	  6).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  
Figure	   6.	   	   Postnatal	   Development	   of	   the	   RMS	   and	   Astrocyte	   Invasion.	   	   Fluorescence	  microscopy	   of	   the	   rostral	   migratory	   stream	   in	   early	   postnatal	   development.	   	   At	   P6,	   sagittal	  sections	  of	  the	  RMS	  reveal	  few	  astrocytes	  in	  the	  core	  of	  the	  RMS.	  	  In	  addition,	  the	  width	  of	  the	  RMS	  is	  comparable	  in	  EphA4+/+	  and	  EphA4-­‐/-­‐	  mice	  at	  P6.	  	  By	  P12,	  many	  astrocytes	  have	  invaded	  the	   developing	   RMS	   and	   oriented	   parallel	   to	   the	   direction	   of	   the	   migrating	   neuroblasts	   in	  EphA4+/+	  mice.	  	  Astrocytes	  appear	  more	  disorganized	  and	  hypertrophic	  in	  EphA4-­‐/-­‐	  mice	  at	  P12.	  	  RMS	  width	   (marked	  by	   red	  dotted	   lines)	  at	  P12	   is	   greater	   in	  EphA4-­‐/-­‐	  mice	   than	   in	  EphA4+/+	  mice,	  with	  an	  increased	  number	  of	  neuroblasts	  extending	  radial	  processes	  into	  the	  parenchyma	  and	   escaping	   from	   the	   RMS.	   	   PECAM	   immunohistochemistry	   reveals	   a	   similar	   parallel	  orientation	  of	  blood	  vessels	  within	  the	  RMS	  of	  EphA4+/+	  and	  EphA4-­‐/-­‐	  mice.	  	  Scale	  bar	  50	  μm.	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To	  investigate	  further	  the	  developmental	  role	  of	  EphA4	  in	  RMS	  boundary	  formation,	  coronal	  sections	  of	  WT,	  EphA4+/-­‐,	  and	  EphA4-­‐/-­‐	  tissue	  were	  processed	  and	  cross-­‐sectional	  areas	  of	  the	  RMS	  from	  each	  sample	  type	  were	  compared.	  	  In	  EphA4+/+	  coronal	  sections,	  tangentially	  migrating	  neuroblasts	  were	  confined	  to	  a	  small	  and	  relatively	  compact	  area	  (Figure	  7A).	  	  As	  expected,	  RMS	  cross-­‐sectional	  analysis	  in	  EphA4-­‐/-­‐	  mice	  revealed	  numerous	  neuroblast	  processes	  that	  extended	  radially	  into	  the	  surrounding	  parenchyma	  (Figure	  7B).	  	  Area	  measurements	  at	  three	  different	  stereotaxic	  coordinates	  in	  each	  mouse	  revealed	  a	  significant	  increase	  in	  cross	  sectional	  RMS	  area	  in	  both	  EphA4+/-­‐	  and	  EphA4-­‐/-­‐	  in	  comparison	  to	  EphA4+/+	  mice	  (n=3	  for	  each	  group,	  *P<0.05	  and	  **P<0.001;	  Student’s	  t-­‐test;	  Figure	  7E).	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Figure	  7.	  	  Persistent	  Role	  of	  EphA4	  in	  Maintaining	  RMS	  Boundaries	  for	  Neuroblast	  
Migration.	   	   Fluorescence	   immunohistochemistry	   of	   coronal	   sections	   of	   the	   RMS	  obtained	  from	  the	  descending	  limb	  and	  elbow	  region	  (indicated	  in	  C)	  reveal	  differences	  between	   the	   restriction	   of	  migrating	   neuroblasts	   in	   the	   adult	   RMS	   of	  EphA4	  WT	   and	  mutant	  mice.	  	  In	  A,	  DCX+	  neuroblasts	  appear	  to	  be	  tightly	  confined	  within	  the	  forebrain	  of	  EphA4	  WT	  mice.	   	   In	  B	   and	  D,	   fluorescence	   immunohistochemistry	  of	   	  EphA4-­‐/-­‐	   and	  
EphA4ΔeGFP/ΔeGFP	   sections	   revealed	   an	   increase	   in	   RMS	   cross-­‐sectional	   area.	   	   DCX+	  neuroblast	  chains	  are	  also	  more	  dispersed.	  	  Scale	  bars	  100	  μm	  (A	  &	  B)	  and	  50	  μm	  (D).	  	  Sagittal	   RMS	   sections	   further	   demonstrated	   changes	   in	   neuroblast	   restriction	   as	   an	  increased	  number	  of	  neuroblasts	  were	  observed	  to	  escape	  the	  RMS	  in	  EphA4-­/-­	  mice	  (G)	  in	   comparison	   to	   EphA4	  WT	   mice	   (F).	   	   RMS	   area	   measurements,	   defined	   by	   DCX	  staining,	  found	  EphA4+/-­	  and	  EphA4-­/-­	  RMS	  areas	  to	  be	  significantly	  larger	  than	  the	  RMS	  area	  of	  WT	  mice	  (*P<0.05	  and	  **P<0.001;	  Student’s	  t-­‐test;	  Figure	  7E).	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Identification	  of	  EphA4-­Expressing	  Cells	  Using	  a	  Novel	  EphA4-­ΔeGFP	  MACS-­FACS	  Approach	  	   Despite	  EphA4’s	  apparent	  role	  in	  defining	  RMS	  boundaries	  and	  regulating	  neuroblast	  migration,	  previous	  research	  remains	  in	  disagreement	  on	  its	  cellular	  location	  in	  the	  postnatal	  brain	  [45	  –	  48].	  	  To	  address	  these	  discrepancies	  concerning	  EphA4	  localization,	  we	  developed	  an	  experimental	  paradigm	  employing	  EphA4-­‐ΔeGFP	  fusion	  protein	  to	  aid	  in	  the	  isolation	  and	  subsequent	  identification	  of	  cell(s)	  expressing	  the	  tyrosine	  kinase	  receptor	  EphA4.	  	   	  	  	  	  	  	  	  	  	   In	  this	  experiment,	  microdissected	  mouse	  SVZ	  and	  RMS	  tissue	  from	  P3,	  P7,	  and	  P12	  
EphA4ΔeGFP/ΔeGFP	  mice	  was	  dissociated	  with	  trypsin	  and	  filtered	  through	  a	  70	  μm	  and	  35	  μm	  cell	  strainer.	  	  The	  resultant	  suspensions	  underwent	  magnetic	  bead-­‐conjugated	  antigen-­‐based	  cell	  sorting	  (MACS)	  as	  described	  in	  the	  Materials	  and	  Methods	  section	  to	  enrich	  for	  neuroblasts.	  	  Antigen-­‐enriched	  populations	  (neuroblasts)	  and	  flow-­‐through	  samples	  were	  then	  analyzed	  with	  fluorescence	  activated	  cell	  sorting	  (FACS)	  or	  flow	  cytometry,	  which	  allowed	  EphA4+	  cell	  populations	  to	  be	  separated	  due	  to	  the	  presence	  of	  GFP.	  	  Processing	  of	  
Figure	   8.	   	   Schematic	   of	   MACS	  
Enrichment	   for	   Populations	   of	  
SVZ-­RMS	  Cells.	  	  Multiple	  rounds	  of	  MACS	   depletion	   (A2B5)	   and	  enrichment	   (PSA-­‐NCAM)	   lead	   to	  neuroblast	   enrichment.	   	   Astrocyte	  enrichment	   (GLAST)	   follows	   a	  similar	   method	   to	   PSA-­‐NCAM	  enrichment.	   	  Adapted	  from	  Miltenyi	  
Biotec.	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the	  neural	  progenitor	  enriched	  (PSA+-­‐fraction)	  or	  flow-­‐through	  samples	  for	  EphA4-­‐ΔeGFP+	  cells	  through	  FACS	  was	  followed	  by	  transcriptional	  analysis	  via	  qRT-­‐PCR	  and	  immunocytochemistry	  (ICC)	  antibody	  labeling	  to	  identify	  the	  cells	  as	  neuroblasts,	  astrocytes,	  or	  endothelial	  cells.	  	  ICC	  antibody	  labeling	  of	  DCX+	  neuroblasts	  and	  GFP	  expression	  (EphA4,	  via	  EphA4-­‐ΔeGFP	  fusion	  protein)	  from	  P12	  EphA4-­‐ΔeGFP	  mice	  revealed	  co-­‐localization	  of	  these	  signals	  on	  DCX+	  neuroblasts,	  suggesting	  that	  EphA4	  is	  normally	  expressed	  on	  migrating	  neuroblasts	  in	  the	  developing	  RMS	  (Figure	  9A).	  	  Initial	  studies	  also	  demonstrate	  the	  efficacy	  of	  MACS-­‐FACS	  techniques	  in	  separating	  GFP+	  cells	  (Green	  Box	  in	  Figure	  9C)	  from	  the	  collected	  MACS	  fractions.	  	  Mixed	  results	  were	  obtained	  for	  cell	  enrichment	  using	  EphA4-­‐ΔeGFP	  MACS-­‐FACS	  techniques	  though,	  which	  necessitated	  other	  experimental	  strategies.	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	   9.	   	   Localization	   of	   EphA4-­ΔeGFP.	   	   (A)	   Single-­‐cell	  suspensions	   from	   P12	   EphA4ΔeGFP/ΔeGFP	   mice	   immunostained	  with	   antibodies	   against	   GFP	   (EphA4,	   via	   EphA4-­‐ΔeGFP	   fusion	  protein)	  and	  DCX	  (neuroblasts).	  	  Note	  the	  co-­‐localization	  of	  GFP	  and	   DCX	   signals	   on	   single	   cells.	   	   (B)	   Simplified	   diagram	  comparing	   a	   single	   EphA4-­‐ΔeGFP	   molecule	   to	   a	   WT	   EphA4	  molecule.	   	   (C)	   Following	   SVZ-­‐RMS	   microdissections,	   flow	  cytometry	  analysis	  of	  single-­‐cell	  suspensions	  from	  WT	  EphA4+/+	  mice	   and	   EphA4-­ΔeGFP	   mice	   detected	   eGFP+	   cells	   in	   EphA4-­‐ΔeGFP	  mice.	  	  The	  detection	  of	  eGFP+	  cells	  was	  revealed	  through	  increased	  GFP	   relative	   intensity	   (green	   box)	   in	   comparison	   to	  cells	   from	  WT	  mice	   (control	   GFP	   relative	   fluorescence	   levels,	  bound	  by	  red	  box).	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To	  increase	  the	  specificity	  of	  MACS-­‐FACS	  cell	  enrichment,	  additional	  experiments	  using	  GFAP:mRFP1	  mice	  were	  used.	  	  By	  performing	  MACS	  enrichments	  for	  PSA	  and	  FAC	  sorting	  for	  RFP+	  cells	  at	  P7,	  separate	  samples	  of	  neuroblasts	  and	  astrocytes	  were	  collected	  and	  confirmed	  through	  measurements	  of	  the	  relative	  normalized	  expression	  of	  DCX	  and	  GFAP	  (Figure	  10A).	  	  As	  expected,	  the	  δ	  isoform	  of	  GFAP	  (GFAPδ),	  which	  is	  typically	  expressed	  in	  astrocytes	  of	  the	  SVZ	  and	  RMS,	  was	  detected	  in	  the	  RFP+	  cell	  population	  (Figure	  10A)	  [40].	  	  Following	  separate	  GFAP:mRFP1	  MACS	  enrichments	  for	  neural	  progenitors	  (PSA+	  cells)	  and	  astrocytes	  (GLAST+	  cells),	  FACS	  was	  used	  to	  either	  enrich	  for	  RFP+	  cells	  or	  to	  remove	  RFP+	  cells	  from	  PSA–enriched	  samples.	  	  The	  purified	  cellular	  populations	  underwent	  qRT-­‐PCR	  for	  transcriptional	  analysis	  (Figure	  10B),	  which	  revealed	  increased	  relative	  expression	  levels	  of	  EphA4	  in	  the	  PSA+	  cell	  fraction	  and	  ephrinA5	  and	  ephrinB1	  in	  the	  RFP+	  cell	  population.	  	  Overall,	  these	  initial	  studies	  suggest	  that	  EphA4	  is	  expressed	  at	  a	  higher	  level	  on	  migrating	  neuroblasts	  in	  the	  RMS	  with	  ephrins	  A5	  and	  B1	  more	  highly	  expressed	  on	  RMS	  astrocytes.	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The	  Role	  of	  EphA4	  Signaling	  in	  Regulating	  Proliferation	  in	  the	  SVZ/RMS	  System	  A	  final	  line	  of	  research	  addressed	  during	  my	  undergraduate	  career	  was	  the	  investigation	  of	  changes	  in	  cellular	  proliferation	  mediated	  by	  EphA4	  in	  the	  SVZ/RMS	  system.	  	  Previous	  research	  by	  Holmberg	  et	  al.	  (2005)	  found	  that	  ephrin-­‐A2	  reverse	  
Figure	   10.	   	   Transcriptional	   Analysis	   of	   SVZ-­RMS	   Cell	   Populations	  
Enriched	   by	   MACS-­FACS	   Using	   qRT-­PCR.	   	   (A)	   Relative	   normalized	  expression	   levels	   of	   transcript	   targets	   (DCX,	   GFAP,	   and	   GFAP	   delta)	   from	  enriched	  P7	  GFAP:mRFP1	  SVZ-­‐RMS	  cell	  populations	  through	  MACS	  selection	  for	  PSA+	  cells,	   followed	  by	  FACS.	   	  FACS	  was	  used	  to	  exclude	  RFP+	  cells	   from	  the	  PSA-­‐enriched	  fraction.	   	  RFP+	  cells	  were	  selected	  via	  FACS	   in	  other	  trials.	  	  (B)	   Relative	   normalized	   expression	   levels	   of	   EphA4	   and	   ephrin	   target	  transcripts	  from	  the	  same	  cell	  populations	  in	  (A).	  	  In	  the	  PSA+	  cell	  fraction,	  the	  level	   of	  EphA4	  expression	   is	   higher	   in	   comparison	   to	   the	  RFP+	   cell	   fraction.	  	  Higher	   relative	  expression	   levels	  of	   ephrin	  A5	  and	  ephrin	  B1	  were	   found	   in	  RFP+	  astrocytes.	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signaling	  negatively	  regulates	  neural	  progenitor	  proliferation	  and	  also	  neurogenesis	  [49].	  	  To	  be	  more	  specific,	  it	  was	  found	  that	  EphA7	  causes	  ephrin-­‐A2	  reverse	  signaling,	  which	  is	  involved	  in	  negatively	  regulating	  the	  proliferation	  of	  neural	  progenitor	  cells.	  	  In	  mice	  lacking	  ephrin-­‐A2,	  cells	  in	  the	  adult	  neural	  stem	  cell	  niche	  were	  found	  to	  proliferate	  more	  and	  have	  a	  shorter	  cell	  cycle.	  	  In	  addition,	  the	  increased	  proliferation	  of	  progenitor	  cells	  led	  to	  a	  greater	  number	  of	  cells	  in	  the	  OB.	  	  By	  interfering	  with	  ephrin-­‐A2	  and	  EphA7	  interactions	  in	  the	  adult	  brain	  of	  WT	  mice,	  proliferation	  was	  disinhibited,	  and	  an	  increase	  in	  neurogenesis	  was	  observed.	  	  Interestingly,	  mixed	  results	  have	  been	  obtained	  concerning	  the	  role	  of	  EphA4	  signaling	  in	  regulating	  proliferation	  in	  the	  SVZ/RMS	  system,	  which	  subsequently	  encouraged	  us	  to	  perform	  preliminary	  experiments	  investigating	  this	  possible	  phenomenon.	  To	  address	  this	  important	  question	  and	  provide	  a	  conclusive	  answer	  in	  response	  to	  the	  field’s	  mixed	  results,	  we	  developed	  a	  comprehensive	  plan	  to	  analyze	  cellular	  proliferation	  in	  the	  developing	  SVZ/RMS	  system.	  	  We	  first	  administered	  2-­‐hr	  BrdU	  pulses	  to	  six-­‐month	  old	  EphA4	  WT	  and	  KO	  mice.	  	  Unfortunately,	  pup	  births	  limited	  our	  first	  experiment	  to	  a	  sample	  population	  of	  n=1	  for	  EphA4	  WT	  and	  n=1	  for	  EphA4	  KO	  mice.	  	  Following	  perfusion,	  serial	  sectioning,	  and	  antibody	  labeling,	  ten	  40	  μm	  RMS	  sections	  from	  coordinates	  2.71	  mm	  bregma,	  6.51	  mm	  interaural	  to	  1.98	  mm	  bregma,	  5.78	  mm	  interaural	  and	  eighteen	  40	  μm	  SVZ	  sections	  from	  coordinates	  1.70	  mm	  bregma,	  5.50	  mm	  interaural	  to	  0.00	  mm	  bregma,	  3.80	  mm	  interaural	  were	  imaged,	  and	  BrdU+	  cells	  were	  counted.	  	  In	  the	  RMS,	  520	  BrdU+	  cells	  were	  found	  in	  the	  EphA4	  WT	  mouse	  in	  comparison	  to	  1167	  BrdU+	  cells	  present	  in	  the	  EphA4	  KO	  mouse,	  denoted	  by	  a	  cellular	  proliferation	  ratio	  of	  2.24:1	  (BrdU+	  EphA4	  KO	  cells:	  BrdU+	  EphA4	  WT	  cells).	  	  SVZ	  counts	  from	  these	  two	  mice	  revealed	  a	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similar	  phenomenon	  as	  1870	  BrdU+	  cells	  were	  found	  in	  the	  SVZ	  of	  EphA4	  WT	  mice,	  while	  4324	  BrdU+	  cells	  were	  counted	  in	  the	  SVZ	  of	  EphA4	  KO	  mice,	  resulting	  in	  a	  cellular	  proliferation	  ratio	  of	  2.31:1.	  	  As	  a	  whole,	  this	  initial	  experiment	  indicated	  that	  EphA4	  may	  play	  an	  important	  role	  in	  regulating	  cellular	  proliferation	  in	  the	  SVZ/RMS	  system.	  	  To	  complement	  this	  data,	  we	  performed	  a	  similar	  pilot	  experiment	  in	  which	  cellular	  proliferation	  was	  investigated	  in	  two-­‐month	  old	  EphA4	  WT	  and	  EphA4+/-­‐	  mice.	  	  Due	  to	  similar	  restrictions	  in	  mouse	  colony	  size,	  a	  sample	  population	  size	  of	  n=1	  was	  used	  for	  EphA4	  WT	  and	  EphA4+/-­‐	  mice.	  	  Following	  a	  similar	  methodology	  to	  the	  first	  proliferation	  study,	  cell	  counting	  in	  the	  RMS	  found	  777	  BrdU+	  cells	  in	  the	  EphA4	  WT	  sample,	  while	  813	  BrdU+	  cells	  were	  counted	  in	  the	  EphA4+/-­‐	  sections,	  resulting	  in	  a	  cellular	  proliferation	  ratio	  of	  1.21:1	  (BrdU+	  EphA4+/-­‐	  cells:	  BrdU+	  EphA4	  WT	  cells).	  	  In	  addition,	  analysis	  of	  SVZ	  tissue	  revealed	  9796	  BrdU+	  cells	  in	  the	  EphA4	  WT	  mouse	  and	  13529	  BrdU+	  cells	  in	  the	  EphA4+/-­‐	  tissue,	  resulting	  in	  a	  cellular	  proliferation	  ration	  of	  1.38:1.	  	  By	  combining	  the	  data	  collected	  from	  the	  initial	  proliferation	  studies	  with	  this	  data,	  it	  becomes	  clear	  that	  EphA4	  may	  play	  an	  important	  dosage-­‐dependent	  role	  in	  regulating	  cellular	  proliferation	  in	  the	  SVZ/RMS	  system	  (Figure	  11).	  	  Overall,	  our	  results	  suggest	  that	  disruption	  of	  EphA4	  signaling	  may	  disinhibit	  cellular	  proliferation	  in	  a	  manner	  similar	  to	  the	  disruption	  of	  ephrin-­‐A2/EphA7	  interaction.	  	  On	  the	  other	  hand,	  the	  reported	  increase	  in	  cellular	  proliferation	  may	  have	  resulted	  from	  a	  ‘bottleneck	  effect,’	  in	  which	  decreased	  cell	  migration	  speed	  allowed	  an	  increased	  number	  of	  cells	  to	  be	  labeled	  with	  the	  proliferative	  marker.	  	  Future	  studies	  investigating	  cellular	  proliferation	  are	  aimed	  at	  increasing	  the	  sample	  population	  size	  to	  establish	  statistical	  significance	  and	  gain	  a	  deeper	  understanding	  of	  the	  role	  of	  EphA4	  in	  regulating	  proliferation	  in	  the	  SVZ/RMS	  neurogenic	  niche.	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Conclusions:	  	   Studies	  over	  the	  past	  several	  decades	  have	  demonstrated	  the	  unique	  complexity	  of	  the	  SVZ/RMS/OB	  neurogenic	  niche	  and	  its	  relevant	  role	  as	  an	  important	  model	  system	  for	  the	  study	  of	  neurogenesis	  and	  cellular	  migration.	  	  By	  investigating	  astrocyte	  proliferation	  and	  infiltration	  in	  this	  system,	  we	  have	  gained	  a	  greater	  understanding	  of	  the	  dynamics	  of	  RMS	  development	  in	  the	  mammalian	  forebrain.	  	  In	  addition,	  our	  study	  of	  RMS	  astrocyte	  morphology	  and	  our	  future	  research	  investigating	  expression	  levels	  of	  GFAPδ	  will	  help	  draw	  comparisons	  between	  glial	  tube	  and	  reactive	  astrocyte	  morphology,	  hopefully	  laying	  a	  strong	  foundation	  for	  the	  development	  of	  glial	  scar	  treatments.	  
Figure	  11.	  	  EphA4	  May	  Regulate	  Cellular	  Proliferation	  in	  the	  SVZ/RMS	  System	  in	  
a	   Dosage	   Dependent	   Manner.	   	   After	   BrdU+	   cells	   were	   counted	   in	   EphA4+/+,	  EphA4+/-­‐,	  and	  EphA4-­‐/-­‐	  tissue,	  cellular	  proliferation	  ratios	  (BrdU+	  EphA4	  KO	  or	  BrdU+	  EphA4+/-­‐	   cells:	   BrdU+	   EphA4	   WT	   cells)	   were	   calculated.	   	   Figure	   11A	   (RMS)	   and	  Figure	  11B	  (SVZ)	  both	  demonstrate	  an	  increase	  in	  cellular	  proliferation	  in	  EphA4+/-­‐	  and	   EphA4-­‐/-­‐	   mice	   in	   a	   dosage	   dependent	   manner.	   	   Polynomial	   trend	   line	   added	  using	  Microsoft	  Excel.	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   Our	  research	  concerning	  the	  tyrosine	  kinase	  receptor	  EphA4	  has	  revealed	  its	  crucial	  role	  in	  the	  development	  and	  maintenance	  of	  the	  SVZ/RMS	  system.	  	  In	  the	  RMS	  of	  mutant	  EphA4	  mice,	  we	  found	  disorganized	  and	  hypertrophic	  astrocytes,	  which	  led	  to	  improper	  astroglial	  boundary	  formation	  and	  abnormal	  neuroblast	  migration	  into	  the	  surrounding	  parenchyma.	  	  Additional	  studies	  found	  increases	  in	  cross-­‐sectional	  RMS	  area	  in	  EphA4-­‐/-­‐	  mice,	  further	  reinforcing	  the	  crucial	  role	  of	  EphA4	  in	  directing	  the	  tangential	  migration	  of	  neuroblasts	  to	  the	  olfactory	  bulb.	  	  To	  determine	  the	  exact	  location	  of	  EphA4	  in	  the	  SVZ/RMS	  neurogenic	  niche,	  a	  novel	  combination	  of	  immunocytochemistry	  and	  MACS/FACS	  techniques	  were	  utilized	  on	  EphA4-­‐ΔeGFP	  and	  hGFAP:mRFP1	  mice.	  	  From	  these	  experiments,	  we	  revealed	  an	  increased	  level	  of	  expression	  of	  EphA4	  in	  the	  PSA+	  cell	  fraction	  (neuroblasts).	  	  Due	  to	  the	  complexity	  of	  this	  system	  though,	  it	  is	  likely	  that	  EphA4	  is	  still	  expressed	  on	  astrocytes	  but	  at	  a	  much	  lower	  level.	  	  Future	  studies	  aimed	  at	  refining	  our	  cell	  sorting	  techniques	  will	  likely	  provide	  definitive	  answers	  to	  the	  question	  of	  exact	  expression	  levels	  throughout	  RMS	  development.	  	   Finally,	  our	  study	  addressed	  the	  possible	  role	  of	  EphA4	  signaling	  in	  regulating	  proliferation	  in	  the	  SVZ/RMS	  system.	  	  By	  using	  an	  experimental	  technique	  employing	  BrdU	  to	  label	  cells	  undergoing	  S	  phase	  of	  the	  cell	  cycle,	  we	  were	  able	  to	  collect	  a	  representative	  picture	  of	  cellular	  proliferation	  in	  EphA4+/+,	  EphA4+/-­‐,	  and	  EphA4-­‐/-­‐	  mice.	  	  From	  our	  initial	  findings,	  it	  appears	  that	  EphA4	  negatively	  regulates	  cell	  proliferation	  in	  the	  SVZ/RMS	  system	  as	  EphA4	  knockout	  transgenic	  mice	  strains	  show	  an	  increased	  number	  of	  BrdU+	  cells	  in	  this	  system.	  	  In	  addition,	  findings	  from	  EphA4+/-­‐	  mice	  suggest	  that	  EphA4-­‐mediated	  repression	  of	  proliferation	  is	  dosage	  dependent	  as	  EphA4+/-­‐	  proliferation	  levels	  fall	  between	  WT	  and	  KO	  mice.	  	  Another	  possible	  explanation	  for	  the	  increase	  in	  cellular	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proliferation	  is	  the	  ‘bottleneck	  effect,’	  in	  which	  decreased	  cell	  migration	  speed	  allowed	  an	  increased	  number	  of	  cells	  to	  be	  labeled	  with	  the	  proliferative	  marker.	  	  Overall,	  our	  experimental	  paradigm	  investigating	  EphA4-­‐dependent	  changes	  in	  proliferation	  provides	  substantial	  evidence	  that	  cellular	  proliferation	  and/or	  migration	  speed	  in	  this	  neurogenic	  niche	  is	  dependent	  upon	  the	  EphA4	  tyrosine	  kinase	  receptor.	  	   Despite	  the	  molecular	  and	  cellular	  nature	  of	  the	  experiments	  that	  I	  performed	  throughout	  my	  undergraduate	  career,	  investigation	  of	  astroglial	  boundary	  formation	  and	  EphA4	  signaling	  in	  the	  RMS	  is	  a	  crucial	  stepping-­‐stone	  for	  future	  stem	  cell	  therapeutics.	  	  By	  gaining	  insight	  into	  the	  molecular	  mechanisms	  involved	  in	  glial	  tube	  formation	  in	  the	  RMS,	  substantial	  progress	  is	  made	  toward	  understanding	  and	  eventually	  treating	  glial	  scars	  formed	  after	  traumatic	  brain	  injury.	  	  In	  addition,	  investigations	  into	  the	  molecular	  mechanisms	  involved	  in	  the	  restriction	  of	  neuroblast	  migration	  in	  the	  developing	  RMS	  may	  unveil	  potential	  molecules	  for	  therapeutic	  intervention	  that	  act	  either	  alone	  on	  endogenous	  neural	  stem	  cells	  or	  together	  with	  autologous	  or	  artificially	  cultured	  pluripotent	  cells.	  	  By	  discovering	  regulators	  of	  neuroblast	  migration,	  these	  molecules	  can	  hopefully	  be	  used	  to	  direct	  stem	  cells	  to	  sites	  of	  injury	  in	  future	  stem	  cell	  therapeutic	  treatments.	  	  Our	  investigation	  into	  neuroblast	  migration	  within	  the	  central	  nervous	  system	  will	  also	  provide	  valuable	  information	  that	  can	  be	  related	  to	  the	  metastasis	  of	  cancerous	  cells	  in	  the	  CNS,	  as	  in	  the	  case	  of	  glioblastoma.	  	  Finally,	  the	  novel	  research	  techniques	  developed	  and	  refined	  over	  the	  course	  of	  my	  undergraduate	  studies	  are	  of	  significant	  importance	  as	  they	  lay	  a	  solid	  foundation	  for	  further	  investigation	  into	  the	  highly	  complex	  SVZ/RMS/OB	  system.	  	  As	  a	  whole,	  our	  research	  into	  astroglial	  boundary	  formation	  and	  the	  critical	  role	  of	  EphA4	  in	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the	  developing	  RMS	  has	  laid	  a	  solid	  foundation	  for	  future	  work	  concerning	  developmental	  neurobiology,	  adult	  neurogenesis,	  and	  stem	  cell	  therapeutics.	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